Composing company history

Company History

How the Company Became an International Provider of Medical Technology

A Company with Tradition and History

Carl Zeiss Meditec AG is one of the world´s leading medical technology companies. The company offers complete diagnostic and treatment solutions for ophthalmic diseases. In the field of microsurgery the company provides innovative visualization solutions. ZEISS´ medical technology portfolio is rounded off by promising future technologies such as intraoperative radiotherapy. The company has ten sites around the world and more than half of the company's 2,400 employees work outside Germany.

Key Milestones in the Development of the Company

Year Event
1846 Carl Zeiss opens a workshop for precision mechanics and optics.
1866 Start of collaboration with Ernst Abbe on the production of lenses based on precise calculations. Microsurgery on finest tissues begins with Carl Zeiss surgical microscopes.
1911 Development of the slit lamp together with Allvar Gullstrand.
1912 Founding of the department for medical optics and ophthalmology.
1953 The OPMI® surgical microscope is presented by Prof. Horst Wullstein for the first time at the World’s Fair in Amsterdam.
1957 Xenon light coagulator – predecessor of the laser used for eye surgery.
1984 Introduction of Humphrey® Field Analyzer (HFA™) Perimeter, a device to measure visual fields. It is primarily used in the diagnosis and management of glaucoma.
Year Event
1991 Reunification of West and East German parts of Carl Zeiss; acquisition of Humphrey Instruments (now Carl Zeiss Meditec, Inc.), a major producer of ophthalmic diagnostic devices.
1997 The first OCT 1 system was launched on the market under the ZEISS brand name and opened up a totally new depth dimension for the diagnosis of retinal diseases.
1999 Non-contact optical biometry with the IOLMaster® opens new possibilities for the treatment of cataract.
2002 Acquisition of Asclepion-Meditec AG (manufacturer of innovative refraction lasers) by the Ophthalmology division of Carl Zeiss AG, leading to the creation of Carl Zeiss Meditec AG.
Introduction of MEL 80™ refractive laser for faster and more precise treatment of visual defects. Carl Zeiss Meditec launches the innovative Stratus OCT™ in the glaucoma and retinal imaging market segment.
2002 With its entry in the commercial register, Carl Zeiss Meditec AG is listed on the German stock exchange in July 2002.
2004 The OPMI® Pentero® neurosurgery microscope provides a comprehensive range of digital visualization possibilities.
2005 Carl Zeiss Meditec moves into the surgical ophthalmology market segment by acquiring IOLTECH S.A., a specialist in intraocular lenses.*
2006 The merger of Carl Zeiss Surgical and Carl Zeiss Meditec creates a market leader in visualization solutions for surgical applications.
Year Event
2006 Surgeons use the VisuMax® femtosecond laser for the correction of visual defects.
2007 The Carl Zeiss Meditec share is listed on the TecDAX of the German stock exchange. The Company strengthens its position in the field of intraocular lenses* by acquiring Acri.Tec AG.
2008 Carl Zeiss Meditec introduces major product innovations to the market: AT LISA® *and AT LISA® toric* are the world’s first real microincision lenses* for refractive microincision cataract surgery (MICS), the OPMI® Lumera® surgical microscope revolutionizes the red reflex, and the Cirrus™ HD-OCT optical coherence tomography shows details of the human eye which have never been seen before.
2009 Carl Zeiss Meditec becomes a solutions provider offering ZEISS Toric Solution*, ZEISS Refractive Laser Solution, ZEISS Ophthalmic Data Management Solution.
2010 INTRABEAM® is an innovative system for breast cancer therapy developed by Carl Zeiss Meditec and proven in numerous clinical studies.
2011 Inauguration of the Center of Application and Research, CARIn, in Bangalore, India, and enhancement of the presence in this market that is vital to Carl Zeiss Meditec.
2011 Acquisition of the ophthalmology business of Spanish dealer IMEX and enhancement of sales activities on the Iberian peninsula.
2012 Inauguration of the Innovation Center for Research and Development in Shanghai, China, to strengthen the company’s presence there.
Year Event
2014 Acquisition of long-standing partner Optronik AS to better serve Turkish market.
2014 Acquisition of US-based manufacturer of intraocular lenses (IOLs) Aaren Scientific broadens portfolio of IOLs from ZEISS in surgical ophthalmology.
2015 Investments in innovative radiotherapy solution for wet age-related macular degeneration developed by Oraya Therapeutics, Inc.
2016 ZEISS is celebrating the 200th birthday of its founding father, Carl Zeiss.

*ZEISS intraocular lenses, microincision lenses and Toric Solution are not for sale in the U.S.